Please login to the form below

Not currently logged in
Email:
Password:

Sanofi partners with QiC Diabetes

Sanofi has confirmed as an industry partner for QiC Diabetes – the first of PMGroup's new Quality in Care programmes recognising good healthcare practice and collaboration in the UK

Sanofi has confirmed as an industry partner for QiC Diabetes – the first of PMGroup's new Quality in Care programmes to recognise and share good healthcare practice and encourage further collaboration in the UK between the NHS, patient groups and the industry in priority therapy areas.

The company has a strong track record of commitment to developing effective solutions for patients with diabetes, with the condition affecting nearly three million people in the UK.

Sanofi joins NHS Diabetes and charity Diabetes UK in partnering the programme.

Andrew Hockey, director of medical operations, Sanofi, said: "Quality in Care recognises initiatives that will bring real benefit for patients; this matches our ambition at Sanofi and we are delighted to be supporting these awards."

7th June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...